Last update :
28/04/2024
Anticancer drug   Oxaliplatin  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Axiplatin Germany
Bendaplatin Germany
Bioezulen Brazil
Celdach Peru
Crisapla Chile, Ecuador, Venezuela
Crisatinox Turkey
Dabenzol Argentina, Ecuador
Dacplat Argentina
Eloxarin Ecuador
Eloxatin Austria, Belgium, Brazil, Chile, Colombia, Egypt, Great Britain, Iran, Italy, Luxembourg, Malaysia, Mexico, New Zealand, Norway, Peru, Portugal, Romania, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, United States of America, Venezuela
Eloxatine France, Morocco, Switzerland
Entia Colombia, Mexico
Euroxaliplatine Germany
Glenoxal Peru
Goxyral Argentina, Ecuador
Kebir Argentina, Peru
Linoxa Turkey
Lisix Chile
Metaplatin Argentina
Oliptino Argentina
Onicol Chile, Peru
Oxalibbs Brazil
Oxaliplan Germany
Riboxatin Germany

Factors which affect stability   Injection   Factors which affect stability : Oxaliplatin        
References
Solvent Sodium chloride 0,9% Induces Degradation 3413
3634
Solvent NaHCO3 Induces Degradation 3634
Temperature Increase Induces Degradation 2259
PH PH >7 Induces Degradation 3634
[Cl-] Induces Degradation 2253

  Mentions Légales